Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population

An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population

The purpose of this study is to determine the effect of Pandel® (hydrocortisone probutate cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface area.

Inclusion Criteria:

• Clinical diagnosis of psoriasis or atopic dermatitis involving more than 20% of body surface area
• Good health with the exception of psoriasis or atopic dermatitis

Exclusion Criteria:

• Any disease affecting the HPA-axis
• Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period